Quantum Pharmaceutical introduces new ordering system for Specials

Quantum Pharmaceutical introduces new ordering system for Specials

August 18 2017 Quantum Pharmaceutical is updating its ordering system for Specials medicines to...

Updated guidance for prescribing specials medicines published

Updated guidance for prescribing specials medicines published

June 15 2016 The Royal Pharmaceutical Society has published new guidance on prescribing specials...

Drug alert issued for Epistatus Oromucosal Solution 10mg/ml

Drug alert issued for Epistatus Oromucosal Solution 10mg/ml

May 31 2016 A drug recall for a batch of the specials product Epistatus (midazolam maleate)...

Drug Tariff updates include specials and unlicensed medicines price amendments

Drug Tariff updates include specials and unlicensed medicines price amendments

February 1 2016 The latest list of prices for specials and unlicensed medicines has been...

RPS invites comments on draft guidance for prescribing specials medicines

RPS invites comments on draft guidance for prescribing specials medicines

November 4 2015 The Royal Pharmaceutical Society is asking for comments on guidance it is...

  • Quantum Pharmaceutical introduces new ordering system for Specials

    Quantum Pharmaceutical introduces new ordering system for Specials

    Friday, 18 August 2017 15:27
  • Updated guidance for prescribing specials medicines published

    Updated guidance for prescribing specials medicines published

    Wednesday, 15 June 2016 14:54
  • Drug alert issued for Epistatus Oromucosal Solution 10mg/ml

    Drug alert issued for Epistatus Oromucosal Solution 10mg/ml

    Sunday, 05 June 2016 22:37
  • Drug Tariff updates include specials and unlicensed medicines price amendments

    Drug Tariff updates include specials and unlicensed medicines price amendments

    Monday, 01 February 2016 12:29
  • RPS invites comments on draft guidance for prescribing specials medicines

    RPS invites comments on draft guidance for prescribing specials medicines

    Wednesday, 04 November 2015 15:45

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

Drug Tariff featured imageAugust 26 2015

Scottish Drug Tariff changes affecting the authorisation process for the supply of specials and imported unlicensed medicines will come into effect on September 1.

An NHS Circular has been issued setting out the changes which apply to Part 7 of the Drug Tariff. Arrangements have been revised for specials for which a reimbursement price is not listed in Part 7S of the Drug Tariff. In addition, the list of items in Part 7S has been extended. The measures are being introduced to help streamline the approval process, says the circular.

For items listed in Part 7S, pharmacy contractors will require no prior authorisation from their Health Board before ordering and dispensing the item, and the contractor will be reimbursed the amount listed there. Any further reimbursement will be paid only in exceptional cases - for example where the item is required next day and out of pocket (OOP) expenses may arise, but the contractor will require prior Health Board authorisation to claim above the tariff price.

For items not listed in Part 7S but available as a commercially made up item, contractors should follow the ‘Generic Framework for Specials Authorisation Process across Scotland’ which is included in the Circular and has also been posted on the Community Pharmacy Scotland website.

The Generic Framework says that no health board authorisation is required for products not listed in Part 7S where:

  • authorisation has been obtained for a patient prescription within last 12 months with less than 20% price variation from original authorisation
  • the preparation is available from an NHS manufacturing unit within Scotland, England or Wales
  • the prescription is endorsed with the fixed non part 7S handling charge as a handling charge (hc)
  • if other OOP expenses apply (including wholesaler handling charges) these should be endorsed as postage and packing costs (pp)

Health board authorisation is otherwise required where the product is not in Part 7S. In addition:

  • contractors should source one quote which includes postage and packing, handling charges, shelf life etc.
  • reauthorisation is required for the same patient and product if price varies by more than 20% from the original authorisation prescription
  • for items prescribed long term, reauthorisation is required after 12 months for clinical validation
  • prescription endorsements should be done electronically and on paper with the invoice price, less any rebate plus any additional cost authorised such as OOP expenses (including wholesaler handling charge) should be endorsed as postage and packing costs (pp)
  • the prescription should be endorsed with the fixed non Part 7S handling charge of £30 as a handling charge (hc)

The Circular also contains details about record keeping requirements and CPS has created a key facts sheet summarising the information.

Links:

SEHD NHS Circular PCA2015(P) 17 

CPS announcements     

Generic Framework for Specials Authorisation Process across Scotland                

CPS - FAQs (Annex B to the Circular)      

CPS - Key Facts

Specials News

September 21 2017 Pharmacy IT systems supplier Cegedim has announced it has commenced beta testing of Pharmacy Manager version 10.3. The new version has specific functionalities for England and...
December 7 2015 Pharmacists in Scotland have been asked to share their views on what politicians need to be made aware of ahead of the Scottish Parliament elections in 2016. The Royal Pharmaceutical Society...